Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, May 14, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
MassBio Pushes Back Against ‘Most Favored Nation’ Drug Pricing Policy Following Executive Order
Life Sciences Times
-
May 14, 2025
Pharma
Sensory Cloud Completes Enrollment for Phase 2a Trial Targeting Refractory Chronic Cough
Life Sciences Times
-
May 14, 2025
Pharma
Faeth Therapeutics Publishes Preclinical Data Supporting Drug-Diet Combo for Metabolism-Driven Cancers
Life Sciences Times
-
May 14, 2025
Pharma
GSK Acquires Phase III-Ready Efimosfermin to Advance Liver Disease Treatment Portfolio
Life Sciences Times
-
May 14, 2025
Pharma
Japan Approves Sarepta’s Gene Therapy ELEVIDYS for Duchenne Muscular Dystrophy
Life Sciences Times
-
May 13, 2025
Pharma
Blade Therapeutics Announces Successful Completion of Phase 1 Clinical Study that Evaluated Co-Administration of Cudetaxestat with Either of Two Approved Therapies for Idiopathic Pulmonary...
Life Sciences Times
-
January 12, 2022
0
Pharma
Hemogenyx Pharmaceuticals and Selexis SA Will Advance Hemogenyx’s Acute Myeloid Leukemia (AML) CDX Bispecific Antibody to Human Trials
Life Sciences Times
-
January 12, 2022
0
Pharma
Panavance Therapeutics Inc. Created to Transform Cancer Treatment
Life Sciences Times
-
January 11, 2022
0
Pharma
Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic Non-Small Cell Lung Cancer
Life Sciences Times
-
January 10, 2022
0
Pharma
Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme From LegoChem Biosciences
Life Sciences Times
-
January 10, 2022
0
Pharma
JAMP and Alvotech Announce Canadian Approval of SIMLANDI™, a High-Concentration Biosimilar to Humira
Life Sciences Times
-
January 10, 2022
0
Pharma
NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial
Life Sciences Times
-
January 10, 2022
0
Pharma
n-Lorem Foundation Notes Latest in Guidance From FDA on Developing ASO Drug Products for Patients With Nano-rare Diseases
Life Sciences Times
-
January 6, 2022
0
Pharma
China NMPA Approves Tislelizumab as Second- or Third-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Life Sciences Times
-
January 6, 2022
0
Pharma
Oral Decitabine and Cedazuridine (ASTX727) Granted Orphan Drug Designation (ODD) by the European Commission for the Treatment of Acute Myeloid Leukemia
Life Sciences Times
-
January 6, 2022
0
Pharma
Prilenia Announces Completion of Patient Enrollment Ahead of Schedule in the Pridopidine Arm of the HEALEY ALS Platform Trial
Life Sciences Times
-
January 5, 2022
0
Pharma
NiKang Therapeutics and AVEO Oncology Announce a Clinical Trial Collaboration and Supply Agreement to Evaluate the Combination of NKT2152, a HIF2α Inhibitor, and FOTIVDA
Life Sciences Times
-
January 5, 2022
0
1
...
36
37
38
...
64
Page 37 of 64
Most Read
Mirvie Launches Encompass™, a First-of-Its-Kind Predictive Test for Preeclampsia, Marking a Shift Toward Personalized Prenatal Care
May 14, 2025
Michael Dowling to Step Down as Northwell Health CEO After 23 Years, John D’Angelo Named Successor
May 14, 2025
Median Technologies Files FDA Application for AI-Powered Lung Cancer Screening Software
May 14, 2025
Eight Sleep Launches Pod 5, the First AI-Powered Sleep System with Temperature Control, Elevation, Sound, and Real-Time Health Monitoring
May 14, 2025